Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
- Citation:
- J Clin Oncol vol 26 (6) 870-876
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 801
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, CA77597, CA11789, CA77406, CA47577, CA35113, CA32291, P30 CA006973, CA41287, U10 CA031946, U10 CA033601, CA45389, CA45808, CA16450, CA77440, CA45564, CA04326, CA21060, CA47642, CA45418, CA77298, CA31983, CA31946
- Corr. Author:
- Authors:
- Charles M. Rudin Ravi Salgia Xiaofei Wang Lydia D. Hodgson Gregory A. Masters Mark Green Everett E. Vokes
- Networks:
- Study
- CALGB-30103
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Article